Metabolic Syndrome as Prognostic Factor for Outcome of Sever SARS-COV-2 Cases.

NCT05477394 | Completed

• 1 other identifier: obsevational
• Study Type: observational
• Target: 90
• Locations: 1 country
• Sites: 1

Brief Summary

SARS-COV-2 crisis is a severe public health concern in the world. It is now well recognized that older age, diabetes mellitus, obesity (BMI \> 30 kg/m2), and hypertension increase the risk of complications and death in SARS-COV-2 patients. This study will describe the spectrum of clinical features, the likely pathophysiologic mechanisms, and potential implications for the management of metabolic syndrome in SARS-COV-2 patients.

Conditions

COVID-19

Outcome Measures

Primary Outcomes (1)

• The period of time that Covid patients spent in intensive care and its outcome.

  We note whether metabolic syndrome in cases of Covid is related to the length of stay in the hospital or not.

  6 months

Secondary Outcomes (1)

• number of Covid patients who needed mechanical ventilation.

  6 months

Eligibility Criteria

• Sex: all
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

• critical SARS-COV-2 patients. * patients admitted to for Sever Pneumonic COVID-19 infection with a confirmed positive RT-PCR for COVID-19 and chest computed tomography that is divided into two groups. * Group one is critical COVID patients with metabolic syndrome . * Group two is critical COVID witout metabolic syndrome . Sample Size: 45 patients for each group

You may qualify if:

• patients admitted to for Sever Pneumonic COVID-19 infection with a confirmed positive RT-PCR for COVID-19 and chest computed tomography that is divided into two groups.
• Group one is critical COVID patients with metabolic syndrome .
• Group two is critical COVID without metabolic syndrome .
• Age 21-50 years old.
• Sex both sexes.
• Patients having metabolic syndrome defined before who have:
• Diabetes mellitus.
• Hypertension.
• Obesity( BMI \< 30 kg/m2)

You may not qualify if:

• \. Patients below 21 years old. 2. Psychiatric disorders. 3. Lack of consent.

Sponsors & Collaborators

• Ain Shams University: lead

Study Sites (1)

Ain Shams University

Cairo, Egypt

Location

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases

Study Officials

• amr mo hilal

  Ain Shams University

  STUDY DIRECTOR

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: March 15, 2022
• First Posted: July 28, 2022
• Study Start: April 1, 2021
• Primary Completion: December 30, 2021
• Study Completion: January 30, 2022
• Last Updated: July 28, 2022

Record last verified: 2022-07

Data Sharing

• IPD Sharing: Will share
• Shared Documents: STUDY PROTOCOL, SAP, CSR
• Time Frame: 6 months
• Access Criteria: send to DR.heba992@gmail.com

Locations

EG (1)